Clinical Trials
2 trialsNCT06383078 2024-04-25
HR070803 in Combination With Oxaliplatin, S-1 Versus NALIRIFOX as Adjuvant Therapy for Pancreatic Cancer
The First Affiliated Hospital with Nanjing Medical University
Phase 2 Not yet recruiting
NCT03660761 2019-04-16
Apatinib in Recurrent or Refractory Intracranial Central Nervous System Malignant Tumors
Shandong Cancer Hospital and Institute
Phase 2 Completed